|
|
||||||||
1 Molekulare Genetik und Epidemiologie von Herpesviren, Robert Koch-Institut, Nordufer 20, 13353 Berlin, Germany
2 Institut für Klinische und Molekulare Virologie, Universität Erlangen-Nürnberg, Schlossgarten 4, 91054 Erlangen, Germany
3 Institut für Lebensmittel, Arzneimittel und Tierseuchen, Invalidenstr. 60, 10557 Berlin, Germany
Correspondence
Bernhard Ehlers
ehlersb{at}rki.de
| ABSTRACT |
|---|
|
|
|---|
Published online ahead of print on 23 June 2006 as DOI 10.1099/vir.0.81977-0.
| INTRODUCTION |
|---|
|
|
|---|
Here, we wanted to further extend knowledge of the ElHV-1 genome, thereby possibly obtaining genetic hints regarding the fulminant pathogenicity of ElHV-1 in Asian elephants. As no cell-culture system is available for ElHV-1, this goal was difficult to achieve. However, with the technique of genome walking, which had already been used to investigate the ElHV-1 gB and DPOL genes (Ehlers et al., 2001
), we were able to extend the genomic characterization of ElHV-1 to a locus of 60 kbp. Within this genomic region, 34 open reading frames (ORFs) were identified and analysed by computer-based analysis, including a prediction of three-dimensional protein structures. Most importantly, a thymidine kinase (TK) gene was identified and this feature represents a novelty in the subfamily Betaherpesvirinae.
| METHODS |
|---|
|
|
|---|
Sequence determination.
PCR fragments obtained by genome walking were sequenced by using BigDye Terminator chemistry and ABI 377 or ABI 3100 automated sequencers (Applied Biosystems). Additional overlapping PCRs were performed for sequence completion with 100 ng elephant DNA by using AmpliTaq Gold (Applied Biosystems) under the following conditions: 12 min activation at 95 °C, 45 cycles with 20 s at 95 °C, 30 s at a primer-dependent annealing temperature (usually 5565 °C) and 23 min at 72 °C, followed by a final extension at 72 °C for 15 min. PCR products were purified of remaining primers and dNTPs by using Microspin S-300 HR or S-400 HR columns (Amersham Biosciences) and sequenced as described above. The double-stranded sequence was determined, with an eightfold redundancy on average. Each base pair was determined from at least two PCR amplimers generated with different primers.
Nucleotide and protein sequence analysis.
The sequence files were assembled with the SeqMan module of the Lasergene software (version 6; GATC). ORF prediction and initial analysis was performed with MacVector (version 8.0; Oxford Molecular Group) and the Genequest module of Lasergene, using Borodowsky matrices. BLAST searches were performed in the ncbi database and the GAP program (with neither internal-gap penalty nor end-gap penalty) from the GCG package (Devereux et al., 1984
) was used for calculating identity percentages.
ORF designation.
Genome orientation and nomenclature of the ElHV-1 ORFs were adapted to the nomenclature of Human herpesvirus 6 (HHV-6A and HHV-6B) and other members of the genus Roseolovirus (Gompels et al., 1995
; Dominguez et al., 1999
). The ORFs unique to ElHV-1 that have no homologues in databases were named provisionally (ORFs AF). Redesignation after detection of additional unique ORFs between the 5' end of the sequence and the left terminus of the genome will be necessary.
Computer-based prediction of three-dimensional protein structures.
The location of the kinase domains within the ORFs of ElHV-1 TK (ORF E) and protein kinase (PK) (U69), respectively, was determined by using the PFAM database of hidden Markov model profiles. Sequence and secondary-structure analysis was performed in the Structure Prediction Meta Server (http://cubic.bioc.columbia.edu/predictprotein/doc/meta_intro.html) and yielded the modelling template PDB 1vyw_C (human Cdk2; Pevarello et al., 2004
) for ElHV-1 PK (U69) and PDB 2Ki5B [herpes simplex virus 1 (HSV-1) TK; Bennett et al., 1999
] for ElHV-1 TK (ORF E). A structural model of the ElHV-1 kinase domain was built in SwissModel by using default settings. Although Cdk2 was identified as a high-scoring template for U69, sequence identity was weak. Therefore, the conserved PK domain of U69, as defined by subdomains (SDs) IXI, was identified by multiple and pairwise alignments of U69 to various PKs and subsequently aligned to Cdk2. Where necessary, the automated alignment between U69 and Cdk2 was corrected manually to ensure an optimized superimposition. On this basis, structural modelling of the U69 PK domain was achieved in SwissModel. Model evaluation was performed by ProQ with reference to secondary-structure predictions by PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/).
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
General ElHV-1 sequence features
The overall G+C content was 42 mol%, which was not distributed uniformly, but ranged from 30 to 60 %. No general depression of the CpG dinucleotide frequency, like in many gammaherpesviruses and viral hosts, was found (ratio observed/expected, 1.08) (Honess et al., 1989
). Direct and inverted repeats of >50 bp were only seen in the non-coding region between ORFs U41 and U42 (Table 1
). This repeat cluster may represent the oriLyt of ElHV-1, as demonstrated experimentally for the homologous position in HHV-6B, murine cytomegalovirus (MCMV) and rat cytomegalovirus (Dominguez et al., 1999
; Masse et al., 1997
; Vink et al., 1997
).
|
|
Gene block III (ORFs U42U46) is not collinear in gene content with those of HHV-6 and HHV-7. ORF U42 encodes a transactivator, ORF U43 a helicaseprimase complex protein, ORF U44 a protein of unknown function and ORF U46 glycoprotein N. A homologue to the HHV-6 ORF U45 is missing in ElHV-1. Instead, two genes without any significant similarity are present (ORFs A and C), the latter possessing a high content of serine, threonine and proline residues. Interspersed is a U4 homologue and ORF B, which exhibits a very weak similarity to HCMV UL27. As HHV-6 U45 encodes a dUTPase, present in all other herpesviruses (Davison & Stow, 2005
), ORFs A or C might encode a distantly related dUTPase. Functional experiments are needed to clarify this issue. A protein of obvious similarity to HHV-6 ORF U47 (HHV-6 glycoprotein O; 738 aa), positioned between blocks III and IV, is also missing. Instead, the much shorter ORF D (213 aa) is present. In this regard, it should be mentioned that the gO glycoproteins of HCMV, MCMV, HHV-6A, HHV-6B and HHV-7 do not share regions of significant sequence conservation, but have similar numbers of cysteine residues (five or six) and N-glycosylation sites (six to 26), as well as comparable pI values (910) (Huber & Compton, 1998
). With seven cysteine residues, five of them in the N-terminal half, seven potential N-glycosylation sites and a pI value of 9.5, ElHV-1 ORF D shows clear parallels. Therefore, ORF D may encode a specific gO version of ElHV-1.
Block IV of ElHV-1, ORFs U48U53, contains all block IV counterparts of HHV-6 and HHV-7, including glycoprotein H (ORF U48), a fusion protein (ORF U49), a virion protein (ORF U50), a G protein-coupled receptor (ORF U51), a protein of unknown function (ORF U52) and a protease (ORF U53). Interspersed between ORFs U48 and U49, an unconserved gene (ORF E) is located that reveals significant similarity to the thymidine kinase genes of alpha- and gammaherpesviruses. Thus, ORF E was identified as a novel TK gene contained in a betaherpesvirus genome.
Genes with significant similarity to ORFs U54 and U55, positioned between blocks IV and V in HHV-6 and HHV-7, are not present in ElHV-1. Instead, ORF F was found, which displays only very low similarity to these two HHV-6 genes (24 and 20 %, respectively). As U54 and U55, as well as their counterparts in HCMV (UL82UL84), represent a family of dUTPase-related genes (Davison & Stow, 2005
), ORF F may also be a member of this group. The small block V (ORFs U56U57) is complete and encodes a capsid and the major capsid protein. Homologues to ORFs U58 and U59, positioned between blocks V and VI in HHV-6 and HHV-7, are present in ElHV-1, but their function is not known.
In the determined part of block VI (HHV-6B U60U77), ORFs U62U65 and U67U68 encode proteins with unknown function. ORF U66 encodes the viral cleavage and packaging protein (terminase). The terminase gene occurs in all sequenced herpesvirus genomes as two exons, separated by a large intron that contains other ORFs on the opposite strand. In our ORF analysis, this situation appeared initially to be similar for ElHV-1, i.e. two exons (245 and 375 aa, respectively) separated by a large intron. However, the deduced protein (620 aa) exhibited a gap of 40 aa in a highly conserved region as seen in a multiple terminase alignment, and was therefore too short to suggest functionality. Directly downstream of exon 1, however, an additional short exon could be predicted through strong splice-acceptor and -donor sites, thereby providing the corresponding coding region of 40 aa. As depicted in Fig. 1
and listed in Table 1
, we propose that the ElHV-1 terminase possesses three exons, namely ORF U66Ex13, with exon 3 located between ORFs U59 and U63 (in HHV-6A and HHV-6B, this exon is named U60 and U66Ex2, respectively).
ORF U69 encodes a serine/threonine PK (a kinase potentially possessing additional ganciclovir-phosphorylating activity) and ORF U70 for an alkaline exonuclease (Fig. 1
; Table 1
).
ElHV-1 is a very distantly related member of the subfamily Betaherpesvirinae
At the nucleotide and amino acid levels, almost all ElHV-1 genes with orthologues in other herpesviruses are related more closely to those of the subfamily Betaherpesvirinae than to those of the subfamilies Gammaherpesvirinae and Alphaherpesvirinae (with the exception of the TK gene). However, the percentages of identity are consistently low. The highest value (44 %) was obtained with DPOL. Five ORFs showed no significant similarity (Table 1
). This confirms the result of the phylogenetic analysis published previously (Ehlers et al., 2001
) that ElHV-1 is a very distant betaherpesvirus.
ElHV-1 encodes a TK and a serine/threonine PK
Sequence alignments of ElHV-1 genes with a series of viral and cellular genes provided initial evidence that ElHV-1 ORF E is a herpesvirus TK with homology to gammaherpesvirus TKs and alphaherpesvirus TKs (Fig. 2a
), whilst ElHV-1 U69 is a herpesvirus PK with homology to HHV6 U69 and HCMV UL97 (Fig. 3a
). This is indicated mainly by the presence of highly conserved SDs IV (for TK) or IXI (for PK), respectively. Distinct functional properties were assigned to some of these SDs. For example, SD I of TKs, consisting of the motif -GXXGXGKT-, forms a so-called glycine loop (or phosphate-binding P loop) and is considered to be characteristic for ATP-binding sites (Saraste et al., 1990
; Matte et al., 1998
). ElHV-1 TK shows sequential and structural similarity to the HSV-1 TK (Fig. 2a, b
). The sequence alignment for ElHV-1 TK includes the five conserved SDs. Particularly, SD I (including glycine residues of the P loop) conforms completely to the consensus sequence motif. In addition, the structural model contains all five SDs as indicated (Fig. 2b
).
|
|
Presence of a TK and a PK gene in ElHV-1 might contribute to the fulminant pathogenicity in Asian elephants
PKs regulate many cellular functions (Edelman et al., 1987
) and herpesviruses utilize their PKs to regulate their own replicative process and modify the cellular machinery (Purves et al., 1993
). It is a well-established fact that TK and PK genes in herpesviruses are generally not absolutely essential for viral growth in vitro, but their deletion reduces the viral pathogenic potential substantially in vivo: TK-negative HSV mutants did not reactivate from latency (Coen et al., 1989
) and a murine gammaherpesvirus 68 mutant with a TK deficiency showed a severe attenuation in the lung (Coleman et al., 2003
). Attenuation in vivo was also observed in TK-negative mutants of channel catfish virus (Zhang & Hanson, 1995
). TK-negative mutants were discussed as a basis for the development of vaccines for the protection of cattle, horses, cats and chickens against the alphaherpesviruses Bovine herpesvirus 1 (Kaashoek et al., 1996
), Equid herpesvirus 1 (Slater et al., 1993
), Felid herpesvirus 1 (Yokoyama et al., 1996
) and infectious laryngotracheitis virus (Han et al., 2002
), respectively. The PK encoded by HCMV UL97 is important for efficient replication of HCMV (Prichard et al., 1999
; Michel & Mertens, 2004
; Marschall et al., 2005
). Therefore, the UL97 protein is considered as a determinant of virus replication and spread in vivo, contributing to major aspects of HCMV pathogenicity. The homologous PK in varicella-zoster virus (VZV) (ORF47) phosphorylates the VZV major immediate-early transactivator, the IE62 protein (Ng et al., 1994
). The VZV PK is important for replication in dendritic cells and spread to other cells (Hu & Cohen, 2005
), as well as for VZV infection and cell-to-cell spread in human skin (Besser et al., 2003
). Obviously, both types of viral kinases contribute to herpesvirus pathogenicity in vivo.
Generally, betaherpesviruses encode a PK (HCMV UL97 homologue), but in contrast to alpha- and gammaherpesviruses they do not encode a TK homologue. With ElHV-1, the first betaherpesvirus encoding a TK in addition to a PK has now been identified. This reflects the unique evolutionary position of the elephant herpesvirus among the herpesviruses of vertebrates, as observed previously in phylogenetic analyses of two conserved ElHV-1 proteins (Ehlers et al., 2001
). As (i) elephants, the hosts of ElHV-1, are members of the mammalian superorder Afrotheria and (ii) the completely sequenced betaherpesviruses infecting hosts of the superorders Laurasiatheria (Artiodactyla) and Euarchontoglires (Primates, Rodentia, Scandentia) do not contain a TK gene, it can be speculated that the ancestor of currently existing primate, rodent, artiodactyl and scandent betaherpesviruses lost the TK gene after the separation of the afrotherian superorder from other superorders in mammalian evolution.
ElHV-1 exhibits fulminant pathogenicity in Asian elephants, but is apathogenic in African elephants. It has been argued that the virus has the opportunity to cross the species barrier from African to Asian elephants in zoological gardens where both species are housed (Richman et al., 1999
). Crossing of the species barrier, associated with high mortality in the new host, is known for several herpesvirus species. For example, the HSV-related Cercopithecine herpesvirus 1, also known as B virus, is apathogenic in rhesus macaques, but causes fatal encephalitis in humans (Whitley & Hilliard, 2001
). Vice versa, HSV-1 can also infect monkeys with often fatal consequences (Mätz-Rensing et al., 2003
). Pseudorabies virus, an alphaherpesvirus of pigs, can infect dogs and cats with rabies-like symptoms and death within a short time (Mettenleiter, 2000
). Crossing of the species barrier was also documented within the subfamily Gammaherpesvirinae. Ovine herpesvirus 2, a clinically inapparent virus in sheep, can infect cattle and pigs. As a consequence, the so-called malignant catarrhal fever develops, a lymphoproliferative disease with high mortality (Reid et al., 1984
; Albini et al., 2003
). ElHV-1 is thought to exhibit cross-species infective properties by developing endotheliotropic elephant disease in the foreign host, the Asian elephant. Although the potential to enter Asian elephant cells is obviously a prerequisite, the unique genetic make-up with respect to kinase genes may be an important factor for the effective spread of the virus into different cell types in the new environment.
Novel treatment options for endotheliotropic herpesvirus disease in Asian elephants?
Famciclovir (FAM) has been used for treatment in two juvenile Asian elephants that presented with symptoms suggestive of endotheliotropic herpesvirus disease and tested PCR-positive for ElHV-1. After a treatment of 34 weeks, they recovered (Schmitt et al., 2000
). FAM is administered in human alphaherpesvirus infections (HSV-1, HSV-2). With the finding of a TK gene in ElHV-1, the use of FAM in ElHV-1-infected, clinically ill elephants makes sense retrospectively. However, ElHV-1 contains also a U69-/UL97-homologous PK gene. This opens up the possibility of therapeutic alternatives, i.e. the use of ganciclovir, aciclovir or penciclovir, as these nucleoside analogues are phosphorylated and thereby activated by pUL97 or related kinases (Zimmermann et al., 1997
; Talarico et al., 1999
; Marschall et al., 2002
). Especially, derivatives of these drugs with increased oral bioavailability, such as valganciclovir, might be promising. A first step could be the initial testing of phosphorylation of these drugs by the ElHV-1-encoded kinases in vitro. As soon as a viral isolate is available, the determination of the drugs' efficacy in inhibiting ElHV-1 replication in cell-culture experiments will be possible.
| ACKNOWLEDGEMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Bennett, M. S., Wien, F., Champness, J. N., Batuwangala, T., Rutherford, T., Summers, W. C., Sun, H., Wright, G. & Sanderson, M. R. (1999). Structure to 1.9 Å resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of aciclovir. FEBS Lett 443, 121125.[CrossRef][Medline]
Besser, J., Sommer, M. H., Zerboni, L., Bagowski, C. P., Ito, H., Moffat, J., Ku, C.-C. & Arvin, A. M. (2003). Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. J Virol 77, 59645974.
Burkhardt, S., Hentschke, J., Weiler, H., Ehlers, B., Ochs, A., Walter, J., Wittstatt, U. & Göltenboth, R. (1999). Elephant herpesvirus a problem for breeding and housing of elephants. Berl Munch Tierarztl Wochenschr 112, 174179 (in German).[Medline]
Chee, M. S., Bankier, A. T., Beck, S. & 12 other authors (1990). Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 154, 125169.[Medline]
Coen, D. M., Kosz-Vnenchak, M., Jacobson, J. G., Leib, D. A., Bogard, C. L., Schaffer, P. A., Tyler, K. L. & Knipe, D. M. (1989). Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A 86, 47364740.
Coleman, H. M., de Lima, B., Morton, V. & Stevenson, P. G. (2003). Murine gammaherpesvirus 68 lacking thymidine kinase shows severe attenuation of lytic cycle replication in vivo but still establishes latency. J Virol 77, 24102417.
Davison, A. J. & Stow, N. D. (2005). New genes from old: redeployment of dUTPase by herpesviruses. J Virol 79, 1288012892.
Davison, A. J., Dolan, A., Akter, P., Addison, C., Dargan, D. J., Alcendor, D. J., McGeoch, D. J. & Hayward, G. S. (2003). The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol 84, 1728.
Devereux, J., Haeberli, P. & Smithies, O. (1984). A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 12, 387395.[Medline]
Dolan, A., Cunningham, C., Hector, R. D. & 12 other authors (2004). Genetic content of wild-type human cytomegalovirus. J Gen Virol 85, 13011312.
Dominguez, G., Dambaugh, T. R., Stamey, F. R., Dewhurst, S., Inoue, N. & Pellett, P. E. (1999). Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J Virol 73, 80408052.
Dunn, W., Chou, C., Li, H., Hai, R., Patterson, D., Stolc, V., Zhu, H. & Liu, F. (2003). Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A 100, 1422314228.
Edelman, A. M., Blumenthal, D. K. & Krebs, E. G. (1987). Protein serine/threonine kinases. Annu Rev Biochem 56, 567613.[Medline]
Ehlers, B., Burkhardt, S., Goltz, M., Bergmann, V., Ochs, A., Weiler, H. & Hentschke, J. (2001). Genetic and ultrastructural characterization of a European isolate of the fatal endotheliotropic elephant herpesvirus. J Gen Virol 82, 475482.
Gompels, U. A., Nicholas, J., Lawrence, G., Jones, M., Thomson, B. J., Martin, M. E. D., Efstathiou, S., Craxton, M. & Macaulay, H. A. (1995). The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209, 2951.[CrossRef][Medline]
Grose, C., Tyler, S., Peters, G., Hiebert, J., Stephens, G. M., Ruyechan, W. T., Jackson, W., Storlie, J. & Tipples, G. A. (2004). Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype. J Virol 78, 67996807.
Han, M. G., Kweon, C. H., Mo, I. P. & Kim, S. J. (2002). Pathogenicity and vaccine efficacy of a thymidine kinase gene deleted infectious laryngotracheitis virus expressing the green fluorescent protein gene. Arch Virol 147, 10171031.[CrossRef][Medline]
Hanks, S. K. & Hunter, T. (1995). Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9, 576596.[Abstract]
Hanks, S. K., Quinn, A. M. & Hunter, T. (1988). The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 4252.
Honess, R. W., Gompels, U. A., Barrell, B. G., Craxton, M., Cameron, K. R., Staden, R., Chang, Y.-N. & Hayward, G. S. (1989). Deviations from expected frequencies of CpG dinucleotides in herpesvirus DNAs may be diagnostic of differences in the states of their latent genomes. J Gen Virol 70, 837855.
Hu, H. & Cohen, J. I. (2005). Varicella-zoster virus open reading frame 47 (ORF47) protein is critical for virus replication in dendritic cells and for spread to other cells. Virology 337, 304311.[CrossRef][Medline]
Huber, M. T. & Compton, T. (1998). The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J Virol 72, 81918197.
Kaashoek, M. J., van Engelenburg, F. A., Moerman, A., Gielkens, A. L., Rijsewijk, F. A. & van Oirschot, J. T. (1996). Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants. Vet Microbiol 48, 143153.[CrossRef][Medline]
Marschall, M., Stein-Gerlach, M., Freitag, M., Kupfer, R., van den Bogaard, M. & Stamminger, T. (2002). Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle for antiviral therapy. J Gen Virol 83, 10131023.
Marschall, M., Marzi, A., aus dem Siepen, P., Jochmann, R., Kalmer, M., Auerochs, S., Lischka, P., Leis, M. & Stamminger, T. (2005). Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J Biol Chem 280, 3335733367.
Masse, M. J. O., Messerle, M. & Mocarski, E. S. (1997). The location and sequence composition of the murine cytomegalovirus replicator (oriLyt). Virology 230, 350360.[CrossRef][Medline]
Matte, A., Tari, L. W. & Delbaere, L. T. (1998). How do kinases transfer phosphoryl groups? Structure 6, 413419.[Medline]
Mätz-Rensing, K., Jentsch, K. D., Rensing, S., Langenhuyzen, S., Verschoor, E., Niphuis, H. & Kaup, F.-J. (2003). Fatal Herpes simplex infection in a group of common marmosets (Callithrix jacchus). Vet Pathol 40, 405411.
McGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C., McNab, D., Perry, L. J., Scott, J. E. & Taylor, P. (1988). The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol 69, 15311574.
McGeoch, D. J., Rixon, F. J. & Davison, A. J. (2006). Topics in herpesvirus genomics and evolution. Virus Res 117, 90104.[CrossRef][Medline]
Mettenleiter, T. C. (2000). Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis state of the art, June 1999. Vet Res 31, 99115.[CrossRef][Medline]
Michel, D. & Mertens, T. (2004). The UL97 protein kinase of human cytomegalovirus and homologues in other herpesviruses: impact on virus and host. Biochim Biophys Acta 1697, 169180.[Medline]
Murphy, E., Rigoutsos, I., Shibuya, T. & Shenk, T. E. (2003a). Reevaluation of human cytomegalovirus coding potential. Proc Natl Acad Sci U S A 100, 1358513590.
Murphy, E., Yu, D., Grimwood, J. & 7 other authors (2003b). Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci U S A 100, 1497614981.
Ng, T. I., Keenan, L., Kinchington, P. R. & Grose, C. (1994). Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol 68, 13501359.
Ossent, P., Guscetti, F., Metzler, A. E., Lang, E. M., Rubel, A. & Hauser, B. (1990). Acute and fatal herpesvirus infection in a young Asian elephant (Elephas maximus). Vet Pathol 27, 131133.[Medline]
Pevarello, P., Brasca, M. G., Amici, R. & 27 other authors (2004). 3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. J Med Chem 47, 33673380.[CrossRef][Medline]
Prichard, M. N., Gao, N., Jairath, S., Mulamba, G., Krosky, P., Coen, D. M., Parker, B. O. & Pari, G. S. (1999). A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J Virol 73, 56635670.
Prichard, M. N., Williams, A. D., Keith, K. A., Harden, E. A. & Kern, E. R. (2006). Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs. Antiviral Res 71, 16.[CrossRef][Medline]
Purves, F. C., Ogle, W. O. & Roizman, B. (1993). Processing of the herpes simplex virus regulatory protein
22 mediated by the UL13 protein kinase determines the accumulation of a subset of
and
mRNAs and proteins in infected cells. Proc Natl Acad Sci U S A 90, 67016705.
Reid, H. W., Buxton, D., Berrie, E., Pow, I. & Finlayson, J. (1984). Malignant catarrhal fever. Vet Rec 114, 581583.[Abstract]
Richman, L. K., Montali, R. J., Garber, R. L. & 7 other authors (1999). Novel endotheliotropic herpesviruses fatal for Asian and African elephants. Science 283, 11711176.
Saraste, M., Sibbald, P. R. & Wittinghofer, A. (1990). The P-loop a common motif in ATP- and GTP-binding proteins. Trends Biochem Sci 15, 430434.[CrossRef][Medline]
Schmitt, D. L., Hardy, D. A., Montali, R. J., Richman, L. K., Lindsay, W. A., Isaza, R. & West, G. (2000). Use of famciclovir for the treatment of endotheliotrophic herpesvirus infections in Asian elephants (Elephas maximus). J Zoo Wildl Med 31, 518522.[Medline]
Siebert, P. D., Chenchik, A., Kellogg, D. E., Lukyanov, K. A. & Lukyanov, S. A. (1995). An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res 23, 10871088.
Slater, J. D., Gibson, J. S. & Field, H. J. (1993). Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals. J Gen Virol 74, 819828.
Talarico, C. L., Burnette, T. C., Miller, W. H. & 8 other authors (1999). Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein. Antimicrob Agents Chemother 43, 19411946.
Ulrich, S., Goltz, M. & Ehlers, B. (1999). Characterization of the DNA polymerase loci of the novel porcine lymphotropic herpesviruses 1 and 2 in domestic and feral pigs. J Gen Virol 80, 31993205.
Vink, C., Beuken, E. & Bruggeman, C. A. (1997). Cloning and functional characterization of the origin of lytic-phase DNA replication of rat cytomegalovirus. J Gen Virol 78, 29632973.[Abstract]
Wagner, M. J., Sharp, J. A. & Summers, W. C. (1981). Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proc Natl Acad Sci U S A 78, 14411445.
Whitley, R. J. & Hilliard, J. K. (2001). Cercopithecine herpesvirus (B virus). In Fields Virology, 4th edn, pp. 28352848. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
Wu, C.-C., Hsu, T.-Y. & Chen, J.-Y. (2005). Characterization of three essential residues in the conserved ATP-binding region of Epstein-Barr virus thymidine kinase. Biochemistry 44, 47854793.[CrossRef][Medline]
Yokoyama, N., Maeda, K., Tohya, Y., Kawaguchi, Y., Shin, Y.-S., Ono, M., Ishiguro, S., Fujikawa, Y. & Mikami, T. (1996). Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats. Arch Virol 141, 481494.[CrossRef][Medline]
Yu, D., Silva, M. C. & Shenk, T. (2003). Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc Natl Acad Sci U S A 100, 1239612401.
Zhang, H. G. & Hanson, L. A. (1995). Deletion of thymidine kinase gene attenuates channel catfish herpesvirus while maintaining infectivity. Virology 209, 658663.[CrossRef][Medline]
Zimmermann, A., Michel, D., Pavic, I., Hampl, W., Lüske, A., Neyts, J., De Clercq, E. & Mertens, T. (1997). Phosphorylation of aciclovir, ganciclovir, penciclovir and S2242 by the cytomegalovirus UL97 protein: a quantitative analysis using recombinant vaccinia viruses. Antiviral Res 36, 3542.[CrossRef][Medline]
Received 23 February 2006;
accepted 19 June 2006.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |